✨ Government Appointments and Medicines Consent




5 JUNE 2014 NEW ZEALAND GAZETTE, No. 59 1631

Foreign Affairs and Trade

Dated this Tuesday, the 13th day of May 2014.
HON MURRAY MCCULLY, Minister of Foreign Affairs.
go3419

Crown Entities Act 2004

Reappointment to the Board of Management of the New Zealand Antarctic Institute

Pursuant to section 28 of the Crown Entities Act 2004,
I reappoint

Robert Fenwick

as the chair of the New Zealand Antarctic Institute Board, as established under the New Zealand Antarctic Institute Act 1996, for a term commencing on 30 June 2014 and expiring on 30 June 2015.

Reappointment to the Board of Management of the New Zealand Antarctic Institute

Pursuant to section 28 of the Crown Entities Act 2004,
I reappoint

Phillip Melchior

as a member of the New Zealand Antarctic Institute Board, as established under the New Zealand Antarctic Institute Act 1996, for a term commencing on 1 July 2014 and expiring on 30 June 2017.

Dated this Tuesday, the 13th day of May 2014.
HON MURRAY MCCULLY, Minister of Foreign Affairs.
go3420

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Alustal Extract of Five Grasses (Initial Treatment)
Active Ingredients: Allergen extracts 0.1IR/mL (Vial 1)
Allergen extracts 1IR/mL (Vial 2)
Allergen extracts 10IR/mL (Vial 3)
Dosage Form: Solution for injection
New Zealand Sponsor: Ebos Group Limited
Manufacturer: Stallergenes SA, Antony, France

Product: Alustal Extract of Five Grasses (Maintenance Treatment)
Active Ingredient: Allergen extracts 10IR/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Ebos Group Limited
Manufacturer: Stallergenes SA, Antony, France

Product: Lucentis
Active Ingredient: Ranibizumab 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma Stein AG, Stein, Switzerland
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Sterigenics Belgium SA, Verviers, Belgium

Product: Oralair (Initial Treatment)
Active Ingredients: Grass pollen extract 100IR (Tablet 1)
Allergen extracts 300IR (Tablet 2)
Dosage Form: Sublingual tablet
New Zealand Sponsor: Ebos Group Limited
Manufacturers: Delpharm Lille SAS, Lys Lez Lannoy, France
Cenexi SAS, Osny, France



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 59





✨ LLM interpretation of page content

🌏 Reappointment to the Board of Management of the New Zealand Antarctic Institute

🌏 External Affairs & Territories
13 May 2014
Reappointment, New Zealand Antarctic Institute, Board of Management, Chair
  • Robert Fenwick, Reappointed as chair of the New Zealand Antarctic Institute Board

  • HON MURRAY MCCULLY, Minister of Foreign Affairs

🌏 Reappointment to the Board of Management of the New Zealand Antarctic Institute

🌏 External Affairs & Territories
13 May 2014
Reappointment, New Zealand Antarctic Institute, Board of Management, Member
  • Phillip Melchior, Reappointed as member of the New Zealand Antarctic Institute Board

  • HON MURRAY MCCULLY, Minister of Foreign Affairs

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution, Consent, Medicines Act 1981